AN2 Therapeutics Other Current Liabilities

AN2 Therapeutics (ANTX) currently reports a other current liabilities of $2.9M as of March 2026. That compares with $4.9M in the prior-year period — down 40.4% year over year. Use the charts on this page to explore AN2 Therapeutics's other current liabilities history and peer comparisons.

AN2 Therapeutics's other current liabilities decreased from $4.9M to $2.9M — a 40.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AN2 Therapeutics reported $2.9M in other current liabilities as of March 2026. That compares with $4.9M in the prior-year period — down 40.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $2.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AN2 Therapeutics, and consider following ANTX for alerts when major investors trade the stock.